Laszlo Kondacs

Dr. Laszlo Kondacs

Kings College London, Biomedical Engineering Department, School of Natural & Mathematical Sciences
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LKLaszlo Kondacs
Laszlo Kondacs
SOSylvain Orenga
Sylvain Orenga
RARosaleen J. Anderson
Rosaleen J. Anderson
EMEmma C.L. Marrs
Emma C.L. Marrs
JPJohn Perry
John Perry
MGMark Gray
Mark Gray
In clinical culture media inoculated with patient samples, selective inhibition of commensal bacteria is essential for accurate diagnosis and effective treatment, as they can mask the presence of pathogenic bacteria. The alanine analogue, 1-aminoethyltetrazole was investigated as a potential alanine racemase inhibitor. For effective uptake and enhanced and selective antibacterial activity, a library of C-terminal 1-aminoethyltetrazole containing di- and oligopeptides were synthesized by solid phase peptide coupling techniques. The investigation of the antimicrobial activity of the synthesised compounds identified several clinically applicable selective inhibitors. These enabled differentiation between the closely related bacteria, Salmonella and Escherichia coli, which can be difficult to discriminate between in a clinical setting. In addition, differentiation between enterococci and other Gram-positive cocci was also seen.